Abiopharma

Director SPOON ALAN G 🟡 adjusted position in 1.4K shares (1 derivative) of DANAHER CORP /DE/ (DHR) at $174.67 Transaction Date: May 01, 2026 | Filing ID: 000125

Director SHULMAN JOHN D 🟢 acquired 19.6K shares of WRAP TECHNOLOGIES, INC. (WRAP) Transaction Date: Apr 01, 2026 | Filing ID: 021130

(99% Neutral) CBRE GROUP, INC. (CBRE) Announces Business Combination

(99% Neutral) ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION) Announces Regulatory Update

Director HOOLEY JOSEPH L 🟢 acquired 43 shares of IDEXX LABORATORIES INC /DE (IDXX) at $560.80 Transaction Date: Apr 30, 2026 | Filing ID: 000069

Shomaker Kelli D 🟢 acquired 290 shares of SMARTFINANCIAL INC. (SMBK) at $41.30 Transaction Date: May 04, 2026 | Filing ID: 000006

Director NABEL ELIZABETH G 🟡 adjusted position in 0 shares (1 derivative) of Moderna, Inc. (MRNA) Transaction Date: Apr 30, 2026 | Filing ID: 000066

📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 6K shares of Dyne Therapeutics, Inc. (at $17.39 each, total $109K) Filed: May 04, 2026 | ID: 029909

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 3K shares of Dyne Therapeutics, Inc. (at $17.39 each, total $55K) Filed: May 04, 2026 | ID: 029908

(99% Neutral) WEX INC. (WEX) Announces Business Combination